Department of Internal Medicine University Hospital Motol 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Pediatric Neurology Thomayer University Hospital Prague Czech Republic

See more in PubMed

Brož, J., Janíčková Žďárská, D., Urbanová, J., Brabec, M., Doničová, V., Štěpánová, R., Martinka, M., & Kvapil, M. (2018). Current level of glycemic control and clinical inertia in subjects using insulin for the treatment of type 1 and type 2 diabetes in The Czech Republic and the Slovak Republic: Results of a multinational, multicenter, observational survey (DIAINFORM). Diabetes Therapy, 9(5), 1897–1906. https://doi.org/10.1007/s13300‐018‐0485‐2

Gerstein, H. C., Miller, M. E., Byington, R. P., Goff, D. C., Bigger, T., Buse, J. B., Cushman, W. C., Genuth, S., Ismail‐Beigi, F., Grimm, R. H., Probstfield, J. L., Simons‐Morton, D. G., & Friedewaldet, W. T. (2008). Effects of intensive glucose lowering in type 2 diabetes. The New England Journal of Medicine, 358(24), 2545–2559.

Lin, Y. K., Hung, M., Sharma, A., Chan, O., Varner, M. W., Staskus, G., & Fisher, S. J. (2019). Impaired awareness of hypoglycemia continues to be a risk factors for severe hypoglycemia despite the use of continuous glucose monitoring systems in type 1 diabetes. Endocrine Practice, 25(6), 517–525. https://doi.org/10.4158/EP‐2018‐0527

Sönmez Sari, E., Semerci Çakmak, V., Çetinkaya Özdemir, S., & Eşsiz Sefer, B. (2024). Hypoglycaemic confidence levels and experiences related to the hypoglycaemia of patients with diabetes: A mixed methods study. The Journal of Clinical Nursing, 33(3), 1022–1035. https://doi.org/10.1111/jocn.17038

Wright, A. D., Cull, C. A., Macleod, K. M., Holman, R. R., & UKPDS Group. (2006). Hypoglycemia in type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73. The Journal of Diabetes Complications, 20(6), 395–401.